Sedative Use in the Last Week of Life and the Implications for End-of-Life Decision Making
Creator
Sykes, Nigel
Thorns, Andrew
Bibliographic Citation
Archives of Internal Medicine 2003 February 10; 163(3): 341- 344
Abstract
BACKGROUND: The use of sedation at the end of life has aroused ethical controversy, attracting accusations of hastening death by gradually increasing sedative doses. The doctrine of double effect has been introduced as an ethical defense. This study aimed to determine how sedative doses change at the end of life and how often the doctrine of double effect might be relevant. METHODS: Case note review was performed of 237 consecutive patients who died in a specialist palliative care unit. Sedative dose changes during the last week of life were noted and survival from admission was compared between groups of patients receiving no sedation, sedation for 7 days, or a commencement of sedation in the last 48 hours of life. There was detailed review of notes from patients who received a marked increase in sedative dose to explore the applicability of the doctrine of double effect. RESULTS: Sedation was given to 48% of patients. Of these, 13% received sedatives for 7 days or more, while 56% commenced sedative use only in the last 48 hours of life. The groups receiving no sedation or sedation for less than 48 hours had the shortest survival from admission (mean, 14.3 and 14.2 days), whereas the 7-day sedation group survived for a mean of 36.6 days (P
Date
2003-02-10Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Opioid Use in Last Week of Life and Implications for End-of-Life Decision-Making
Thorns, Andrew; Sykes, Nigel (2000-07-29)